Assure to Attend Investor Conferences in December 2022
Assure Holdings Corp. (NASDAQ: IONM) announced its participation in two investor conferences in December 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Assure Holdings Corp. (NASDAQ: IONM) announced its participation in two investor conferences in December 2022. Management will engage in one-on-one meetings at the Benchmark Discovery One-on-One Investor Conference on December 1 and the Roth Capital Deer Valley Conference on December 15-16. Assure specializes in intraoperative neuromonitoring and remote neurology services, providing clinical support during high-risk surgeries. The company emphasizes patient safety and real-time monitoring during procedures, aiming to deliver exceptional surgical care.
Details
News Market Reaction – IONM
The recorded move for IONM in the trading session of this news was +6.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DENVER, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in December 2022:
- The Benchmark Discovery One-on-One Investor Conference on December 1, 2022. The conference offers emerging growth and dynamic publicly traded companies access to institutions and individuals in a unique one-on-one format. Assure management will participate in one-on-one meetings with prospective investors and other interested parties.
- Roth Capital Deer Valley Conference on December 15-16, 2022. This invitation only event provides a forum for public companies to tell their stories to investors. One-on-one and group meetings will be held throughout the conference.
Neither of these events include central presentations.
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.
Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
Scott.Kozak@assureiom.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.